Escolar Documentos
Profissional Documentos
Cultura Documentos
Sponsored by
PERFECTUS
BIOMED
© 2017 MA Healthcare Ltd
All rights reserved. No reproduction, transmission or copying of this publication is allowed without written
permission. No part of this publication may be reproduced, stored in a retrieval system, or transmitted
in any form or by any means, mechanical, electronic, photocopying, recording, or otherwise, without the
prior written permission of MA Healthcare Ltd or in accordance with the relevant copyright legislation.
Although the editor and MA Healthcare Ltd have taken great care to ensure accuracy, MA Healthcare Ltd
will not be liable for any errors of omission or inaccuracies in this publication.
Published by: MA Healthcare Ltd, St Jude’s Church, Dulwich Road, London SE24 0PB, UK
Contents
Forward5
Wound Assessment and Diagnostics 6
Effective Wound Bed Preparation, Infection and Biofilm 8
Cost-effective Wound Management 10
Pressure Care 11
Innovation in North America 12
Best Laboratory/Preclinical Study 14
Clinical Research 18
Patient Wellbeing 20
Compression Therapy for Venous and Lymphatic Disorders 22
Professional Education 23
Innovation24
Veteran and Military Wound Care 26
Innovative New Dressing 28
Innovative New Product 29
Best Research in a Developing Country 30
MEDLINE
LISTED
IMPACT
FACTOR
Dr Rachel Webb
Editor, Journal of Wound Care
Sponsored by
Michelle Deeth
Head of Clinical Services North, Urgo Medical UK
How do you think this award will impact practice and research in wound care?
Wound assessment is an area in wound care that cannot be ignored. I feel sure that due
to the CQUIN we will start to see the emergence of more pathways, greater evidence-
based care, which is driven by patient focused research. Patients are also taking greater
responsibility for their care, questioning practice and challenging the evidence. This award
will raise the profile of wound assessment, advances in treatment and clinical developments.
How does this award change people’s perception of the role of wound assessment and
diagnostics in wound care?
It keeps wound assessment and diagnostics high on the tissue viability agenda. It is a useful
platform for sharing best practice and demonstrates the good work that is being done
within this important area of care.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
Be bold and brave! Don’t be afraid to challenge the norm. Generate the evidence, share it
and use it for the benefit of the patient.
WINNER
Chris Murphy
CEO, Bluedrop Medical
Describe the work you have done, which has resulted in you winning a JWC award
Up to 25% of patients with diabetes will develop a foot ulcer at some point in their life.
These ulcers often take months to heal and if not treated early can result in amputation and
may even be life threatening. Bluedrop Medical is developing a device that takes a daily scan
of the soles of a diabetic patient’s feet, taking the form of a bathroom scales. The user steps
on the device once a day for 20 seconds. The information collected is reviewed using advanced algorithms and
clinical reviewers. If an active ulcer or the pre-signs of ulceration are detected the patient and their clinician are
notified, allowing for the earliest possible intervention. Prevention of diabetic foot ulcers would result in more
time for clinicians to devote to treating wounds that do occur as well as focusing on other prevention and risk
reduction strategies such as debridement, pressure offloading and education. This would have a further effect of
reduction in the rate of ulceration.
How do you think winning this award will affect your work in the future?
To be chosen as a winner in two categories by a prominent panel of expert judges, representative of the diversity of
disciplines and organisations that make up the wound care sector is a huge honour. We are grateful to receive these
awards and see them as an acknowledgement of the way in which our team continually strive to develop solutions
that benefit both patients and the healthcare system as a whole. It also reflects the increased awareness in the
clinical community of the need for increased efforts to prevent these devastating ulcers before they develop.
Sponsored by
Karen Woosey
Marketing Director, PAUL HARTMANN Ltd
Why did you support this award?
HARTMANN is delighted to have supported this important award around effective wound
bed preparation, specifically relating to the roles of infection and biofilm. There is growing
evidence that good tissue hydration may be the most important external factor responsible
for optimal wound healing. We are excited to have launched two innovative hydro-
responsive wound dressings (HRWD), HydroClean plus and HydroTac. These are unique
products that facilitate optimal wound bed preparation and help keep wounds in a balanced
moist environment, therefore optimising healing efficiency.
Why is it important for the JWC to recognise excellence through the Wound Bed
Preparation, Infection and Biofilm award?
The current financial crisis and rising costs of services, along with higher patient numbers
to care for, all spell out a huge challenge for all involved in the management and care of
patients with wounds. Effective wound bed preparation can lead to faster healing times and
a reduction in the occurrence of critical colonisation/infection, thereby reducing treatment
time and costs.
How do you think this award will impact practice and research in wound care?
Recognising the achievements of clinicians and scientists in wound care will inspire and
motivate other workers involved in the field to strive for better patient outcomes.
How has this award changed people’s perception of the role of infection and biofilm
research in wound care?
Knowledge and understanding comes before action. Communicating and educating wound
care health professionals about the role of infection and biofilm, provides a bedrock on
which better treatments and patient outcomes can be based.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
Enabling change can sometimes be difficult, especially in a discipline such as wound care
that suffers lack of funding and a low priority profile in medicine. But the objectives of
achieving positive change are the same in all aspects of medicine and relate for the most
part to better patient outcomes. Having the mind set of achieving this goal is probably the
most important aspect in getting there.
WINNER
Jennifer Hurlow & Jennifer Gaddy
Canterbury Christ Church University Center and Vanderbilt
University Medical
Please describe the work you have done which resulted in you winning a JWC award.
The aim of our study was to analyse wound biofilm from a clinical perspective. This required the
establishment of a link between the clinical setting and the microscopic laboratory. A clinical
algorithm for biofilm identification was used to choose macroscopic wound samples; 75% of these
samples were confirmed by advanced microscopy to contain biofilm despite the use of modern
antiseptic wound dressings and, in some cases, systemic antibiotics. It was found that adherence to
the biofilm based wound care (BBWC) paradigm was difficult in the outpatient setting.
How do you think winning this award will affect your work in the future?
It confirms interest in our findings. Biofilm is accepted to be a roadblock to wound healing. The realisation that many current wound
care strategies are ineffective in managing biofilm will motivate future work to clarify related implications.
How has winning this award changed people’s perception of your role?
We hope that the recognition of our research will encourage others to establish a link between the scientific laboratory and the
clinical wound care setting. This link creates the potential to clarify long held assumptions which will allow wound science to advance.
WINNER
Kumaresan Nagarajan and
Cardiothoracic Surgical Team
New Cross Hospital Wolverhampton
Describe the work you have done which resulted in you winning a JWC award.
Minimal invasive techniques have become the benchmark of progression in the last decade.
Embracing this in the tumultuous NHS climate and proving ourselves was a big challenge.
Coronary artery bypass surgery is the most common cardiac procedure with saphenous vein harvest having the longest incision
in all surgical procedures. Endoscopic vein harvest has improved patient recovery with reduced length of hospital stay and drastic
reduction in leg wound infection. We were able to successfully prove significant saving despite the cost of harvest kit.
How do you think winning this award will affect your work in the future?
This award will vindicate our team’s belief of embracing progress and implementing it to optimise patient care. This would help us gain
funding for future projects. The research this enabled will generate evidence templates for future advances in cardiothoracic surgery.
How has winning this award changed people’s perception of your role?
This award will garner respect within our trust and the region. Our cardiothoracic team at New Cross, Wolverhampton currently
stands second in having the lowest mortality rate across UK. This would help us in proclaiming our progress.
How do you think winning this award will affect your work in the future?
Using the same approach, the tissue viability team in NHS Greater Glasgow and Clyde intend to tackle other issues. In this year’s work
plan we intend to look at moisture lesion prevention.
How has winning this award changed people’s perception of your role?
In NHS Greater Glasgow and Clyde the tissue viability team is valued for the contributions we make to patient care. I think winning this
award consolidates the good we are doing and gives recognition to our team.
Tierney has been the driving force behind Seating Matters In association with the Royal College of Surgeons in Ireland, I
research, partnering with leading researchers at Ulster developed and validated an instrument for the assessment of
University to conduct a clinical trial exploring the effectiveness patient knowledge, attitudes and behaviours. To date, no other
of specialist seating provision in pressure ulcer prevention. By such instrument exists. The KPUP is a rigorously developed reliable
using prescribed seating and applying The Four Principles of and valid instrument, which can be used in further research,
Pressure Management in Seating, pressure ulcer incidence was clinical practice and education to evaluate patients’ knowledge of,
reduced by 88.3%. Tierney and her clinical team work tirelessly and attitudes and behaviours towards pressure ulcer prevention.
disseminating these results through clinical training and sharing It is designed as a short tool for ease of administration and
knowledge on how to improve patient care using evidence- scoring, and could be used to evaluate the efficacy of educational
based practice. interventions in the field of pressure ulcer prevention.
Sponsored by
Ross Huntley
Director of Sales and Marketing, Advancis Medical
How do you think this award will impact practice and research in wound care?
Our hope is that this award will raise the profile, provide transparency and inspiration for
clinicians across North America to not only embrace the innovative ideas that are currently
being delivered and introduced by the likes of those shortlisted in this category, but
also inspire them to challenge themselves and their colleagues to continue to share the
unbelievable work that they do.
How will this award change people’s perception of research and innovation
in North America?
Rather than a need to change people’s perception, the key aim for us is to support clinicians
with the knowledge that whether it be new research, innovation in new treatments and
regimes, or indeed innovations in the effective management of transitional care, they are
not alone and that their work is hugely important not just to their patient cohort but to
their colleagues, and to the wound care community across the globe.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
Embrace collaborative working with multiple stakeholders across multiple areas, and
engage in the new technologies and innovation that is continually being evolved. Delivering
improved patient outcomes and cost-effective wound management will be the focus of a
broad range of people across multidisciplines, and by engaging with these stakeholders you
will find that these common goals can be achieved.
Describe the work you have done which resulted in you winning a JWC award.
I have been working in the infectious diseases field for more than two decades. My research has been focused on drug resistant
pathogens and their biofilms. We established testing methodologies and for the first time showed antimicrobial efficacy of a
pocket-size cold plasma technology. We successfully demonstrated antibacterial, antifungal and antibiofilm properties of this
novel wound care device. Although there are several technologies generating cold plasma, this technology is novel due to its size,
reduced cost, being portable with no requirement for any noble gas, and ease of application. This work will lead to additional
discoveries and recognition of the importance of non-drug based wound care technologies.
How do you think winning this award will affect your work in the future?
I strive to be an innovative researcher and try to find solutions that one day may save a limb or life. It is encouraging and
rewarding to see our work has been recognised by JWC, a visionary organisation and the leading source of up-to-date research
on wound care.
What advice would you give to wound-care practitioners and researchers aspiring to achieve positive change within the field?
Strive for learning and excellence; be innovative; adapt to changes; be informed about scientific gaps and clinical needs; be a
team player; be passionate about science; and understand critical importance of scientific ethics as you take your journey in
education, research or patient care.
Sponsored by
Why is it important for the JWC Awards to recognise excellence through the
Laboratory/Preclinical Study award?
Recognition of excellence in research raises the profile of the work and achieves wider
recognition of current laboratory studies and their implications in the clinical setting.
How do you think this award will impact on practice and research in wound care?
By awarding and publishing high-quality research, researchers and practitioners are inspired
to excel and to set new standards for wound and patient care.
What advice would you give to clinicians and researchers aspiring to achieve
positive change within their role?
While learning and adopting best practices yourself will achieve positive change,
capturing that learning and adopting this within the professional education of others will
multiply the impact. As such, when you are armed with new and better insight, assisting
in the professional education of others may often be the most effective way to achieve
positive change.
WINNER
Dilip Thomas
Postgraduate Researcher, Centre for Research in Medical
Devices, NUI Galway
Describe the work you have done which resulted in you winning a JWC award.
My preclinical research is centred around the development and testing of a biomaterial-based
stem cell delivery device as a therapeutic strategy for ‘no option’ Critical Limb Ischaemia
(CLI) patients. CLI patients, due to the lack of sufficient blood supply, suffer from non-healing
ulcers and tissue damage, which further leads to foot amputation in a third of the patient population. In order to enhance the
therapeutic efficacy of stem cells, cells were encapsulated in collagen ‘microgels’—to promote high cell survival and retention. I
demonstrated that tuning the properties of the microgels prime and enhance the angiogenic capacity of stem cells via paracrine
release of trophic factors when delivered to an ischemic, slow healing wound.
How do you think winning this award will affect your work in the future?
The recognition of my work by the JWC highlights the impact of research to health professionals, translational scientists and peers in
the area of wound care. The award also certifies a high standard based on the quality of work to obtain further funding from research
agencies. From the research and translational standpoint, future work will focus on understanding the mechanism of action while
compiling safety and toxicology data for the first-in-human clinical trial.
Wiegand has been working on laboratory tests that help to Vellettaz and team generated an autologous bilayers skin
identify pathogens that cause wound infection. Her work on substitute in a three-dimensional fibrin matrix, intelligently
antiseptics, fluid management systems and negative pressure produced by Tissue Engineering. The structural and
have been the subject of many publications and presentations. ultrastructural features were compatible with skin grafting,
Wiegand has an amazing skill for devising new laboratory proving effective in the treatment of surgical wounds induced
methods and applying them to practical solutions. The in a porcine model.
balance between being a ‘pure’ scientist and understanding
the relevance to the patient and clinician is a rare talent, and
Wiegand has this insight which clearly shows in the prolific
work that she does, individually and as part of a team.
Sponsored by
Lorraine Grothier
Head of Clinical Services, Urgo Medical
Why is it important for the JWC to recognise excellence through the Clinical
Research award?
Clinical research can be costly both in terms of resource and time. It takes dedication and
commitment from the individuals involved but it is usually driven by a passion and the
desire to find answers and solutions to clinical issues. Giving recognition to those who
undertake clinical research not only offers some reward for their efforts but allows them to
share what they have learnt and may help to inspire others to implement their findings or
contribute towards the body of evidence.
How do you think this award will impact practice and research in wound care?
By studying and identifying the risk factors for surgical site infection (SSI) in this patient
group and the associated costs, this research allows clinicians to be proactive with
regards to patient safety. This will lead to new protocols to reduce risk and improve
patient outcomes.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
Identify the gaps in your knowledge and/or practice which can potentially lead to positive
change in that area. Don’t work in isolation, working with specialists and multidisciplinary
teams can provide you with greater insight into what is possible and achievable as well as
providing a sounding board and support for new ideas. Finally, make sure you communicate
with all the stakeholders involved.
WINNER
Ross Atkinson, Anna Jones,
Karen Ousey & John Stephenson
The University of Huddersfield
Describe the work you have done which resulted in you winning a JWC award.
In patients who underwent spinal surgery, using advanced statistical methods, we
found: an increased risk of SSI in those whose operation involved greater numbers
of vertebral levels (odds of SSI increased by 26% for each additional level involved); controlling for number of vertebral
levels, odds of SSI increased by 5.6 in those having surgery primarily on the thoracic spine. We also aimed to determine:
whether SSI had any impact on patient survival; and the main interventions (and associated costs) used to manage SSI.
We conducted a survival analysis showing that life expectancy is 141 days shorter in SSI patients than non-SSI patients;
corresponding to 34.5 years of life lost nationally per year. The analysis of SSI management and related costs in this
patient group determined that hospital stay is around 90% longer in patients with SSI. Around 23.5% of patients required
re-operation on 1-10 occasions. Increased hospital stay and return to theatre accounted for almost all SSI-related costs;
2.5 times those of non-SSI patients, excluding costs of community care, and individual and societal costs.
How do you think winning this award will affect your work in the future?
We hope that the evidence from these studies may raise awareness of the importance of SSI as a complication of
surgery for spinal metastasis and the procedural factors which are significantly associated with its occurrence.
In association with
Ellie Lindsay
Founder of The Lindsay Leg Club
Why is it important for the JWC to recognise excellence through this award?
This award celebrates collaborations between clinicians and academic colleagues who have
initiated interventions to measure and articulate explanations for wellbeing, exploring
and documenting how this knowledge can be used to enhance patient care and the
psychological wellbeing of those living with lymphoedema and/or wounds.
How do you think this award will impact practice and research in wound care?
These awards enable clinicians and academics to raise the profile of innovation. By
disseminating and publishing findings, recipients of the JWC awards can promote new
concepts and present evidence of enhanced patient experiences more widely within the
wound care and health care communities.
How does this award change people’s perception of the role of patient wellbeing?
Research has demonstrated the importance of social interaction on both wellbeing and
wound healing, clearly demonstrating the importance of promoting self-empowerment
which ultimately leads to improved patient adherance, better healing rates and overall
outcomes. Beneficiaries of these awards have initiated many interventions to measure
and enhance wellbeing.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
In today’s fiscal climate NHS providers tend to focus on wound healing as a key outcome
measure for patients. While this is clearly very important, a focus on the patients’ quality
of life tends to get left behind. Therefore, it behoves clinicians and researchers to be
entrepreneurial in their approach to wound management while maintaining the emphasis
on the ultimate goal of patient wellbeing. Effecting change inevitably requires collaboration
at various levels—communicating ideas and strategies and potentially sharing values,
planning, action and reflection. Always remember as professionals striving to bring about
change to achieve your aspirations it is always necessary to unite and work in partnership
with various disciplines and organisations—not in isolation!
WINNER
Anne Williams
Lymphoedema Nurse Consultant and Lecturer, Queen
Margaret University, Edinburgh
Describe the work you have done which resulted in you winning a JWC award.
I was honoured to win the Patient Wellbeing award this year. I have worked with people who have
lymphoedema, lipoedema and leg ulceration for over 20 years. The lymphatic system and related
conditions such as lymphoedema and lipoedema are poorly understood, and this has driven
my passion for developing services and establishing a better evidence base through research. I won the award for my contribution to
person-centred NHS and third sector service developments—from London to the Highlands of Scotland—and my contribution as
a researcher and educator. My research focus has included: the science of compression therapy; manual lymph drainage; supported
self-care; and patient experiences. This has enabled me contribute to a wide range of patient-focused activities in the UK and Europe,
including co-chairing the development of a recent Best Practice Guideline in the Management of Lipoedema.
WINNER
Healogics Team
Crawley, Horsham and Mid-Sussex
Describe the work you have done which resulted in you winning a JWC award.
This is a team nomination for a venous leg ulcer/chronic oedema service providing care
across five different locations for 4 years. Our approach is to establish an accurate diagnosis
and engage with the patient and their carers to provide the most efficacious compression
therapy as quickly as possible. We prioritise building a therapeutic relationship with the
patients and their carers to ensure high levels of adherence. The team use a variety of compression methods based on
pathways and an educational assessment of the patient. The nurse-patient therapeutic relationship is based around continuity
of care, shared decision making and education. Our lead nurses are trained in both lymphoedema and tissue viability which
allows them to choose the best possible pathway to treat the oedema present based on national and best practice guidelines.
Elwell and colleagues set up an expert lower limb group to Edwards has demonstrated the effectiveness of introducing
create work streams for cellulitis, deep vein thrombosis (DVT) compression therapy for the management of patients with
and leg ulceration. Currently the streams for cellulitis and burns to their lower legs. This protocol has been incorporated
DVT have been agreed in place and continually monitored into a Chronic Burn Management Pathway and as community
by group members. The leg ulceration pathway is in the pilot nurses are familiar with compression they are happy to manage
stage with steps to underpin knowledge across the trust burn patients with the therapy.
before a full roll out. These streams have reduced duplication
of care, streamlined the patient journey and improved patient
experience. The development of the clinically led expert lower
limb group has allowed reflection on the things we do well and
how we can develop this to benefit all.
WINNER
Kevin Woo
Assistant Professor & Advanced Wound Consultant, Queen’s
University, Canada
Describe the work you have done which resulted in you winning a JWC award.
The management of diabetic foot ulcers (DFUs) requires comprehensive and lifelong behavioural
modifications that entail regular foot care, exercise, dietary changes, smoking cessation, and
frequent blood glucose testing. I am leading a research team at Queen’s University to develop
an online support group, a ‘foot club’, for people with DFUs, to promote chronic disease self-management and treatment adherence.
The innovative use of social media has the potential to widen access of health information and make contact with populations that are
hard to reach or isolated because of their geographical location, cultural dispositions, and socioeconomic status. In partnership with the
Canadian Association of Wound Care and Canadian Diabetes Association, we envision the online platform to be an ideal conduit for
knowledge transfer to people with diabetes and potential health-care providers.
How do you think winning this award will affect your work in the future?
I am so thrilled and honoured to be the recipient of this award. This award has motivated to me to work harder and be more
patient centred! My overall research objective is to address the health needs and safety of the frail older population with chronic
and complex conditions, especially those with chronic wounds. Integral to my programme of research are projects that will explore
strategies to promote chronic disease management. I am currently undertaking a project to examine health service use among
people with diabetes and first amputation. I am also very fortunate to work with the International skin tear advisory panel (ISTAP)
to explore ways to address education in skin tears.
How has winning this award changed people’s perception of your role?
I got a call from my director and dean congratulating me on my achievement.
In association with
Jackie Stephen-Haynes
Chair Wound Care Alliance UK
Why is it important for the JWC to recognise excellence through the Innovation Award?
Innnovation occurs when people are prepared to view new solutions to existing challenges.
They often require thinking differently and having the courage of your convictions to
investigate the innovation and to implement.
How do you think this award will impact practice and research in wound care?
Every 20 seconds somewhere in the world, a limb is amputated as a result of diabetes. The
ability to predict the formation of diabetic foot ulceration, to enable their early detection and
support the delivery of more effective clinical and financial outcomes is essential for the care
of patients at risk of or presenting with a diabetic foot ulcer. A new innovation can also act as
a spring-board for further research. The use of scanning and the cloud for data analysis and an
innovative algorithm has the ability to implemented nationally and even internationally.
What advice would you give to clinicians and researchers aspiring to achieve positive
change within their role?
The way to making change is by making choices and to secure support to manage the
change. Procrastination occurs when the challenge is greater than our energy, so working as
a team (Team remember Together Everyone Achieves More) is essential. Positive change may
of course be the right thing to do, but that doesn’t make it easy. So allow yourself some
thinking time and spend time really thinking about what you want to achieve and why you
want to achieve it. Think about who are the people that can support you or why you can
work in partnership with. Remember that positive change requires someone to start and
someone to follow. So garner support and think of those that might try to sabotage your
idea and what you can do to avoid this. Develop the ability to articulate clearly what the
positive change can achieve or help you to acvhieve. A briefing paper might also be needed
and if necessary get support with this. Share and celebrate the small successes, these can
inspire others to work with you!
WINNER
Chris Murphy
CEO, Bluedrop Medical Thomas
Describe the work you have done which resulted in you winning a JWC award.
Diabetic foot ulcers often take months to heal and if not treated early can result in amputation
and may even be life threatening. Bluedrop Medical is developing a device that takes a daily scan
of the soles of a diabetic patient’s feet, taking the form of a bathroom scales. If an active ulcer
or the pre-signs of ulceration are detected the patient and their clinician are notified, allowing
for the earliest possible intervention. Bluedrop Medical’s device builds upon research proven to prevent up to 70% of
ulcers in high risk diabetes patients. High risk patients have up to a 30% rate of ulceration per year and 84% of all diabetic
foot ulcers come from this group. There is therefore a highly-targeted population that would benefit from this system.
How has winning this award changed people’s perception of your role?
External validation is always important, especially when developing a new product. Winning this award will undoubtedly
positively impact the perception of our organisation to the clinical community.
Supported by
Claire Stephens
Founder and Chief Executive Officer, Woundcare4Heroes UK
How do you think this award will impact practice and research in wound care?
We are hopeful this award category will stimulate health practitioners in the future to look
at the services they currently offer for the traumatically injured veteran community within
their area and assist in the identification of new methodologies to continue to improve the
services we are able to deliver through practice-based research.
The ability to improve traumatic wound aftercare services exists for all patients through the
cross pollination of knowledge and skills deeming the potential impact on practice as far
wider reaching than the veteran community.
How has this award changed people’s perception of the role of military wound care?
Wound care procedures and practice developed through our military practitioners during
times of conflict have significantly helped to shape trauma after care wound practice within
our NHS generally and the importance of capturing this legacy cannot be understated.
In general, people’s perceptions are changing and the realisation of the need for specific
tailored services and life-long care pathways is now well accepted.
WINNER
Reza Jafari
Lymphoedema Therapist, Woundcare4Heroes UK
Describe the work you have done which resulted in you winning a JWC award.
I’m so humbled to have been chosen for this award. It’s a tremendous honour to be
acknowledged by such an esteemed journal. Since I joined Woundcare4Heroes, I have been
treating veterans of our armed services who suffer from lymphoedema. These patients present
a varied and complex set of functional impairments with moderate to severe oedema as well as
secondary neuromusculoskeletal disorders resulting from oedematous conditions. We are a dedicated team who are committed
to offering our veterans multidisciplinary specialist care and comprehensive rehabilitation programme. The nature of my role
is collaborative and I interact with various stakeholders. This award is a recognition of my continuous efforts to take a holistic,
individualised and flexible approach in addressing the physical, emotional and mental needs of our veterans. Winning this award is
also a recognition of the expertise of our team in the innovative thinking and development of leading-edge solutions in the fields
of wound care and lymphology.
How do you think winning this award will affect your work in the future?
With recognition comes responsibility and the chance to be more influential to find new avenues to make a positive difference to
the veterans’ lives. I am now honour-bound to fulfil my duties with more passion, diligence and integrity.
WINNER
HydroClean Plus
PAUL HARTMANN Ltd
How will winning the award influence the future direction of your work?
HydroClean Plus is part of a sequential wound treatment solution called HydroTherapy. This award will highlight
the use of HydroTherapy (HydroClean Plus for wound bed preparation and HydroTac to boost epithelialisation
in terms of the positive benefits that it can bring. As such more practitioners will become aware that there are
simpler and less painful wound debridement options that are as/or more effective than current treatments.
Biatain Silicone is designed according to the Coloplast UrgoClean Ag is an innovation in silver dressings since as it has
Design DNA. This means users will experience an intuitive the cleaning power to fight local infection. Launched in 2016 it
and non-medical looking product with a fresh, lifestyle- has antibiofilm efficacy providing a complete cleaning action of
oriented design. Intuitive and aseptic application potentially the wound bed. It reduces the bacterial load within the wound
minimises the risk of contamination while applying the through a fast and broad-spectrum antimicrobial efficacy,
dressing. The 3-piece non-touch is designed for just that, as including bacterial strains resistant to antibiotics.
it communicates easy opening and handling of the product,
it also reduces the risk of infection from fingers or gloves
touching the wound or dressing. Biatain Silicone is designed
in a cool grey colour. An honest and demystifying colour
because it does not try to imitate the skin colour as this
seems to fail more often than succeed.
WINNER
Lundatex system
PressCise AB
How will winning the award influence the future direction of your work?
We hope that this will open up many eyes to pressure controlled compression treatment. The fact that the award
comes from Journal of Wound Care, a journal written for our main target group, gives us confidence that our
product is appreciated by the medical world. This of course gives us an extra push when it comes to getting our
product out on a bigger market, and takes us one step closer to our mission of pressure controlled compression
treatment for every patient!
WINNER
Moses Murandu
Senior Lecturer, University of Wolverhampton
Describe the work you have done, which has resulted in you winning the JWC
2017 Best Research in a Developing Country
Winning this award is a great personal honour. My work using granulated sugar for the
management of necrotic exuding wounds commenced in February 2009 as a pilot study which
lead to a randomised controlled trial. The results were promising therefore a trial of using
Telemedicine to help informal carers manage their relatives’ wounds in Botswana and Zimbabwe was undertaken. The
wounds of all six patients treated by this method have healed.
How do you think winning this award will affect your work in the future?
The Award has sparked an interest from industry that certain business individuals are mobilising to invest into this work.
How has winning this award changed people’s perception of your role?
The award has increased the credibility of my work. The Vice Chancellor and the Dean of the Faculty at the University of
Wolverhampton are very pleased as this increased the research image within the university.
Sponsored by
PERFECTUS
BIOMED
The Journal of Wound Care would like to thank all sponsors and supporters for participation in the JWC Awards 2017